Tag Archives: KURA

Hot Warren Buffett Stocks For 2021

Stocks discussed on the Lightning Round segment of Jim Cramer’s Mad Money Program, Monday, December 12.

Bullish Calls

Gilead (NASDAQ:GILD): Not likely to sell it, and could be a buy.

CyberArk (NASDAQ:CYBR): Bullish on stock.

Smith & Wesson (NASDAQ:SWHC): Stock appears cheap.

Bearish Calls

Ford (NYSE:F): Cramer said Ford is a good company, but GM (NYSE:GM) has better momentum. Also, Ford is in the crosshairs of incoming president Donald Trump.

PolyOne (NYSE:POL): Cramer likes the chemicals business, but his pick in the sector is Dow (NYSE:DOW).

Hot Warren Buffett Stocks For 2021: Bioanalytical Systems, Inc.(BASI)

Bioanalytical Systems, Inc., incorporated on July 17, 1975, is an international contract research organization providing drug discovery and development services and analytical instruments. The Company’s clients and partners include pharmaceutical, biotechnology, academic and government organizations. The Company derives its revenues from sales of its research services and drug development tools. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and biomolecule drug candidates. The Company’s principal clients are scientists engaged in analytical chemistry, drug safety evaluation, clinical trials, drug metabolism studies, pharmacokinetics and basic research from small start-up biotechnology companies to many of the global pharmaceutical companies. The Company operates in two business segments: contract research services and research products, both of which addresses the bioanalytical, preclinical, and clinical research needs of drug developers.

Services

This segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. Product Characterization, Method Development, and Validation: Analytical methods, primarily performed in West Lafayette, Indiana, determine potency, purity, chemical composition, structure, and physical properties of a compound. Bioanalytical Testing: The Company analyzes specimens from preclinical and clinical trials to measure drug and metabolite concentrations in complex biological matrices. Bioanalysis is performed at its facilities in West Lafayette, Indiana. Stability Testing: The Company tests stability of drug substances and formulated drug products, and maintains storage facilities in West Lafayette, Indiana. In Vivo Pharmacology: The Company provides preclinical in vivo sampling services for the continuous monitoring of chemical changes in life, in particular, how a drug enters, travels thr! ough, and is metabolized in living systems. Those services are performed in customized facilities in West Lafayette and Evansville, Indiana using its robotic Culex Automated Pharmacology System. Preclinical and Pathology Services: The Company provides pharmacokinetic and safety testing in studies ranging from acute safety monitoring of drugs and medical devices to chronic, multi-year oncogenicity studies in its Evansville, Indiana site.

Research Products

This segment designs, develops, manufactures, and markets in vivo sampling systems and accessories (including disposables, training, and systems qualification); physiology monitoring tools; and liquid chromatography and electrochemistry instruments platforms. Analytical Products: The analytical products consist of the Company’s liquid chromatographic and electrochemical instruments with associated accessories. The critical component of these products is the Epsilon electrochemical platform. The market is principally academic institutions and industrial research companies. In vivo Sampling Products: The in vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments. These are used by pharmaceutical researchers to dose animals and collect biological samples (blood, bile, urine, microdialysate, feces or any bio-fluid) from the animals. The Culex products offer reduction in test model use and comparable reduction in labor. The line also includes in vivo sampling devices sold to drug developers and medical research centers to assist in the study of various medical conditions, including stroke, depression, Alzheimer’s and Parkinson’s diseases, diabetes, and osteoporosis. Vetronics’ Products: The Vetronics’ products consist of instruments and related software to monitor and diagnose cardiac function (electro-cardiogram), and measure other vital physiological parameters primarily in cats and dogs in veterinary clinics.

The Company competes with Covance, Inc.; Pharmaceut! ical Prod! uct Development, Inc.; Charles River Laboratories, Inc., and Quintiles Transnational Holdings, Inc.

Advisors’ Opinion:

  • [By Max Byerly]

    Headlines about Bioanalytical Systems (NASDAQ:BASI) have been trending positive this week, according to Accern. The research firm scores the sentiment of media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bioanalytical Systems earned a news sentiment score of 0.27 on Accern’s scale. Accern also gave media headlines about the company an impact score of 47.5882570492565 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Hot Warren Buffett Stocks For 2021: Heritage-Crystal Clean, Inc.(HCCI)

Heritage-Crystal Clean, Inc., through its subsidiary, Heritage-Crystal Clean, LLC, provides parts cleaning, and hazardous and non-hazardous waste services to small and mid-sized customers in the manufacturing and vehicle maintenance sectors. It operates in two segments: Environmental Services and Oil Business. The Environmental Services segment offers parts cleaning, containerized waste management, vacuum truck, and antifreeze recycling services. This segment also provides oily water disposal and treatment, oil filter recycling, on-site cleaning, and waste management services, as well as sells solvents, machines, absorbents, and accessories. The Oil Business segment collects used oil and sells recycled fuel oil, as well as engages in the re-refining of used oil into lubricant base oil and by-products. This segment also collects and disposes waste water. As of January 03, 2015, the company operated through 84 branches serving approximately 100,000 customer locations. Heritage-Crystal Clean, Inc. was incorporated in 2007 and is headquartered in Elgin, Illinois.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Heritage-Crystal Clean Inc  (NASDAQ:HCCI)Q4 2018 Earnings Conference CallMarch 06, 2019, 10:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Shares of Heritage-Crystal Clean, Inc. (NASDAQ:HCCI) have received a consensus rating of “Buy” from the nine ratings firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have given a buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $25.40.

Hot Warren Buffett Stocks For 2021: Revlon, Inc.(REV)

Revlon, Inc., incorporated on April 24, 1992, manufactures, markets and sells around the world a range of beauty and personal care products, including color cosmetics, hair color, hair care and hair treatments, as well as beauty tools, men’s grooming products, anti-perspirant deodorants, fragrances, skincare and other beauty care products. The Company operates through three segments: Consumer, Professional and Other. The Company conducts its business through its operating subsidiary, Revlon Consumer Products Corporation (Products Corporation) and its subsidiaries.

The Company maintains separate Websites, including www.revlon.com, www.almay.com, www.revloncolorsilk.com, www.revlonprofessional.com, www.americancrew.com, www.cnd.com and www.mitchum.com, dedicated to the Revlon, Almay, Revlon ColorSilk, Revlon Professional, American Crew, CND and Mitchum brands, respectively. Each of these Websites feature product and promotional information for the brands. The Company operates a research and development facility in Edison, New Jersey for products within its Consumer segment. The Company has research facilities for its products within the Professional segment in the United States (in California and Florida), Spain and Mexico. The Company’s principal customers for its Consumer segment include large volume retailers and chain drug stores, including retailers, such as Walmart, CVS and Target in the United States, Shoppers DrugMart in Canada, A.S. Watson & Co. retail chains in Asia Pacific and Europe and Walgreens Boots Alliance in the United States and the United Kingdom Walmart and its affiliates around the world. The Company’s principal customers for its Professional segment include Beauty Systems Group, Salon Centric and Ulta Salon, Cosmetics and Fragrance, as well as individual hair and nail salons and other distributors to professional salons.

Consumer Segment

The Company’s Consumer segment includes cosmetics, hair color and hair care, beauty tools, anti-perspirant! deodorants, fragrances and skincare products sold in approximately 130 countries in large volume retailers, chain drug and food stores, chemist shops, hypermarkets, general merchandise stores, the Internet/e-commerce, television shopping, department stores, one-stop shopping beauty retailers, specialty cosmetics stores and perfumeries in the United States and internationally. The Company manufactures and markets a range of cosmetics, including face, lip, eye and nail products. The Company sells a range of cosmetics under its Revlon brand, which are designed to fulfill consumer wants and needs, and are principally priced in the upper range for large volume retailers. The Revlon brand consists of face makeup, including foundation, powder, blush and concealers; lip makeup, including lipstick, lip gloss and lip liner; eye makeup, including mascaras, eyeliners, eye shadows and brow products, and nail color and nail care lines. Its franchises within the Revlon brand include Revlon ColorStay, which offers consumers a range of products with long-wearing technology; Revlon PhotoReady products that are offered in face and eye makeup and are designed with photochromatic pigments that bend and reflect light; Revlon Age Defying, which consists of face makeup for women in the over-35 age bracket, with ingredients to help reduce the appearance of fine lines and wrinkles; Revlon Super Lustrous, which is the Company’s wax-based lipcolor and is offered in a range of shades of lipstick and lip gloss, and Revlon Mascara, which consists of a collection of over five mascaras, each with a lash benefit, including lash definition, length, volume, magnified volume and length, and an all-in-one formula.

The Company’s Almay brand consists of hypo-allergenic, dermatologist-tested, fragrance-free cosmetics and skincare products. The Almay brand consists of face makeup, including foundation, pressed powder, primer and concealer; eye makeup, including eye shadows, mascaras and eyeliners; lip makeup, and makeup removers. ! Franchise! s within the Almay brand include Almay Smart Shade in face; Almay Intense i-Color in eye, and Almay Color + Care in lip. The Company’s SinfulColors and Pure Ice brands consist primarily of nail enamels, available in various bold, vivid and on-trend colors.

The Company sells both hair color and hair care products throughout the world to large volume retailers and other retailers, primarily under the Company’s Revlon ColorSilk franchise, as well as under the premium priced Llongueras brand in Spain. Revlon ColorSilk products provide radiant, long-lasting color that leaves hair nourished, hydrated and ultra-conditioned. The Company sells Revlon beauty tools, which include nail, eye and manicure and pedicure grooming tools, eye lash curlers and a full line of makeup brushes under the Revlon brand name. The Company sells a selection of fragrances, including perfumes, eau de toilettes, colognes and body sprays. The Company’s portfolio includes fragrances under globally-recognized brand names, such as Charlie and Jean Nate. The Company sells Mitchum anti-perspirant deodorant products for men and women, with ingredients that provide consumers with approximately 48 hours of protection. The Company sells skincare products in the United States and in global markets under various regional brands, including the Company’s Natural Honey and Gatineau brands.

Professional Segment

The Company’s Professional segment includes a line of products sold to hair and nail salons, and professional salon distributors, including hair color, shampoos, conditioners, styling products, nail polishes and nail enhancements. The Professional segment also includes a multi-cultural line sold in both professional salons, large volume retailers and other retailers. The Company’s Revlon Professional brand includes hair color, hair care and hair treatment products that are distributed to professional salons, salon professionals and salon distributors, and sold in over 60 countries. Revlon Professional salo! n product! s include Revlonissimo NMT, Nutri Color Creme, Sensor Perm and Revlon Professional Equave.

The Company sells men’s shampoos, conditioners, gels and other hair care, and grooming products for use and sale by professional salons under the American Crew brand name. American Crew is sold in over 30 countries. The Company also sells unisex hair products under the d:fi brand, which is a value-priced full line of cleansing, conditioning and styling products. The Company sells nail enhancement systems and nail color and treatment products and services for use by the professional nail salon industry under the CND brand name. CND offers professional nail, hand and foot care products, and CND-branded products are sold in over 75 countries. CND nail products include CND Shellac brand 14+ day nail color system, which delivers 14+ days of flawless wear, superior color and mirror shine with zero dry-time and no nail damage, and CND Vinylux weekly polish, a nail polish that uses a patent-pending technology and lasts approximately a week. While ordinary polishes become brittle and deteriorate over time, CND Vinylux dries with exposure to natural light to a flawless finish and strengthens its resistance to chips over time. The Company also sells professional hair products under brand names, such as Orofluido, UniqOne and Intercosmo. The Company sells multi-cultural hair-care products to professional salons, large volume retailers and other retailers, primarily in the United States under the Creme of Nature brand.

Other Segment

The Company’s Other segment primarily includes the distribution of prestige, designer and celebrity fragrances, cosmetics and skincare products, such as Burberry and Rihanna branded products. The Other segment includes the operating results of the CBB business, which develops, manufactures, markets and distributes fragrances, and other beauty products, principally through department stores and selective distribution in international territories.

T! he Compan! y competes with L’Oreal S.A., The Procter & Gamble Company, Avon Products, Inc., Coty, Inc., Shiseido Co., Johnson & Johnson, Kao Corp., Henkel AG & Co., Mary Kay Inc., Hand & Nail Harmony, Inc., Oriflame Holding AG, Markwins International Corporation, LVMH Moet Henessy Louis Vuitton SE, Elizabeth Arden, Inc., Boots UK Limited and The Estee Lauder Companies Inc.

Advisors’ Opinion:

  • [By Max Byerly]

    Revlon (NYSE:REV) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Tuesday.

  • [By Max Byerly]

    An issue of Revlon Inc (NYSE:REV) bonds fell 2% as a percentage of their face value during trading on Thursday. The high-yield debt issue has a 5.75% coupon and will mature on February 15, 2021. The debt is now trading at $80.50 and was trading at $84.88 one week ago. Price moves in a company’s bonds in credit markets often anticipate parallel moves in its share price.

  • [By Logan Wallace]

    News headlines about Revlon (NYSE:REV) have been trending somewhat positive recently, according to Accern Sentiment. The research group rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Revlon earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the company an impact score of 47.276202232048 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Hot Warren Buffett Stocks For 2021: Kura Oncology, Inc.(KURA)

We are a clinical stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. We focus on the development of small molecule product candidates that target cell signaling pathways that are important to driving the progression of certain cancers. We aim to employ molecular diagnostics to identify patients with cancers who are likely to benefit from our targeted product candidates.
Advancements in cancer genetics and new molecular diagnostic tools are helping define why some patients respond to a particular therapy while other patients receive little to no clinical benefit. This new era in cancer drug discovery and development offers the potential for innovative treatments that are safer and more effective for patients with particular cancers.   Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Kura Oncology, Inc.  (NASDAQ:KURA)Q4 2018 Earnings Conference CallMarch 05, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    BidaskClub lowered shares of Kura Oncology (NASDAQ:KURA) from a hold rating to a sell rating in a research note issued to investors on Tuesday morning.

  • [By Shane Hupp]

    Kura Oncology (NASDAQ:KURA) was the target of unusually large options trading on Thursday. Stock investors bought 699 put options on the company. This represents an increase of 694% compared to the typical daily volume of 88 put options.

Hot Warren Buffett Stocks For 2021: TRACON Pharmaceuticals, Inc.(TCON)

TRACON Pharmaceuticals, Inc., incorporated on October 28, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration (wet AMD) and fibrotic diseases. The Company’s research focuses on antibodies that bind to the endoglin receptor, which is essential to angiogenesis (the process of new blood vessel formation) and a contributor to fibrosis (tissue scarring). The Company’s lead product candidate, TRC105, is an endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor (VEGF) pathway. TRC205 is being developed for the treatment of fibrotic disease. The Company is also developing TRC102, a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma.

TRC105

The Company is developing TRC105 for use in combination with agents that inhibit angiogenesis by targeting the VEGF pathway. VEGF is required for angiogenesis. TRC105 binds to the endoglin receptor at a precise location to inhibit endothelial cell activation and angiogenesis. TRC105 has been studied in over six completed Phase II clinical trials and approximately three completed Phase I clinical trials, and is being dosed in over five Phase II clinical trials. TRC105 is focused on approximately two orphan indications, gestational trophoblastic neoplasia (GTN) and angiosarcoma. The next tier of development includes ongoing Phase II trials in renal cell carcinoma, glioblastoma and hepatocellular carcinoma. The Company has produced formulations of TRC105 for development in ophthalmology, which are developed for the treatment of wet AMD, the cause of blindness in the Western world.

TRC205

The Company’s TRC205 is a humanized, deimmunized anti-endoglin antibody. TRC205 is being developed for the treatment of fibrotic diseases, including nonalcoholic ! steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF).

TRC102

The Company is developing TRC102 (methoxyamine hydrochloride) to reverse resistance to specific chemotherapeutics by inhibiting base excision repair (BER). TRC102 interrupts BER by binding within apurinic/apyrimidinic (AP) sites, converting the AP site to a substrate for the enzyme topoisomerase II, which cleaves TRC102-bound deoxy ribonucleic acid (DNA), resulting in an accumulation of DNA strand breaks that trigger cellular apoptosis or programmed cell death. TRC102 is being developed to reverse resistance to Temodar, an alkylating chemotherapeutic, as well as to Alimta and Fludara, two antimetabolite chemotherapeutics. TRC102 began Phase II development through a Phase II clinical trial that combines TRC102 in patients with mesothelioma, as well as a Phase II clinical trial of TRC102 in patients with glioblastoma.

The Company competes with Pfizer, Inc., Acceleron Pharma Inc., Amgen, Inc., MedImmune LLC, OncoMed Pharmaceuticals Inc., Regeneron Pharmaceuticals, Inc., Roche AG, Genfit Corp., Intercept Pharmaceuticals, Inc., Conatus Pharmaceuticals Inc., Galmed Medical Research Ltd., Gilead Sciences, Inc., Immuron Ltd., Shire plc, Mochida Pharmaceutical Co., Ltd., NasVax Ltd., Raptor Pharmaceutical Corp., Takeda Pharmaceutical Company Limited, InterMune, Inc., Boehringer Ingelheim, Biogen Idec., Bristol-Myers Squibb, Celgene Corporation, Fibrogen, Inc., Gilead, Janssen Pharmaceuticals Inc., Novartis AG, Sanofi S.A, Tesaro, Inc. and AbbVie Inc.

Advisors’ Opinion:

  • [By Stephan Byrd]

    TRACON Pharmaceuticals Inc (NASDAQ:TCON) fell 12.3% during trading on Wednesday . The company traded as low as $1.23 and last traded at $1.21. 896,880 shares changed hands during trading, an increase of 112% from the average session volume of 422,831 shares. The stock had previously closed at $1.38.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on TRACON Pharmaceuticals (TCON)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Own For 2019

Shares of Clean Energy Fuels Corp (NASDAQ:CLNE) were down 15.6% during trading on Thursday . The stock traded as low as $3.05 and last traded at $3.13. Approximately 5,742,302 shares traded hands during mid-day trading, an increase of 232% from the average daily volume of 1,731,432 shares. The stock had previously closed at $3.71.

Several analysts have recently commented on CLNE shares. Zacks Investment Research upgraded shares of Clean Energy Fuels from a “hold” rating to a “buy” rating and set a $3.25 price target on the stock in a research report on Friday, June 15th. BidaskClub upgraded shares of Clean Energy Fuels from a “hold” rating to a “buy” rating in a research report on Wednesday, May 23rd. ValuEngine upgraded shares of Clean Energy Fuels from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd. Finally, Raymond James lowered shares of Clean Energy Fuels from a “market perform” rating to an “underperform” rating in a research report on Thursday. They noted that the move was a valuation call.

Top 10 Clean Energy Stocks To Own For 2019: Kura Oncology, Inc.(KURA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub lowered shares of Kura Oncology (NASDAQ:KURA) from a hold rating to a sell rating in a research note issued to investors on Tuesday morning.

  • [By Shane Hupp]

    Kura Oncology (NASDAQ:KURA) was the target of unusually large options trading on Thursday. Stock investors bought 699 put options on the company. This represents an increase of 694% compared to the typical daily volume of 88 put options.

Top 10 Clean Energy Stocks To Own For 2019: Valley National Bancorp(VLY)

Advisors’ Opinion:

  • [By Shane Hupp]

    Valley National Bancorp (NYSE:VLY) has been assigned a consensus rating of “Hold” from the nine brokerages that are covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating on the company. The average 12-month price target among analysts that have covered the stock in the last year is $13.96.

  • [By Logan Wallace]

    SG Americas Securities LLC raised its position in Valley National Bancorp (NYSE:VLY) by 213.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 164,630 shares of the financial services provider’s stock after buying an additional 112,156 shares during the quarter. SG Americas Securities LLC’s holdings in Valley National Bancorp were worth $2,002,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Federated Investors Inc. PA lessened its holdings in Valley National Bank (NYSE:VLY) by 12.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 352,694 shares of the financial services provider’s stock after selling 49,476 shares during the period. Federated Investors Inc. PA owned about 0.11% of Valley National Bank worth $4,395,000 at the end of the most recent quarter.

Top 10 Clean Energy Stocks To Own For 2019: VIVUS, Inc.(VVUS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on VIVUS (VVUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    However, VivoPower and our other penny stocks to watch this week already saw big gains. After looking at our 10 top penny stocks to watch, we’ll show you a small-cap stock with serious profit potential in its future…

    Penny Stock Current Share Price Law Week’s Gain
    VivoPower International Plc. (Nasdaq: VVPR) $3.05 88.57%
    Euro Tech Holdings Co. (Nasdaq: CLWT) $3.77 75.11%
    Boxlight Corp. (Nasdaq: BOXL) $6.36 65.38%
    Chine Recycling Energy Corp. (Nasdaq: CREG) $2.01 45.92%
    Vivis Inc. (Nasdaq: VVUS) $0.52 38.82%
    HC2 Holdings Inc. (NYSE: HCHC) $6.79 33.49%
    Biostar Pharmaceuticals Inc. (Nasdaq: BSPM) $2.67 32.23%
    Turtle Beach Corp. (Nasdaq: HEAR) $6.99 30.19%
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $3.30 29.24%
    Rexahn Pharmaceuticals Inc. (NYSE: RNN) $2.11 29.19%

    While the gains of last week’s top penny stocks are exciting, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Logan Wallace]

    Media stories about VIVUS (NASDAQ:VVUS) have been trending somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. VIVUS earned a news impact score of 0.13 on Accern’s scale. Accern also gave press coverage about the biopharmaceutical company an impact score of 47.022479468622 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Money Morning News Team]

    Seadrill’s rally demonstrates how profitable penny stocks can be for savvy investors. With Seadrill’s gains already on the books, we’ll look at a stock that’s on track to generate tremendous returns – a small cap that just completed a groundbreaking acquisition with huge profit potential…

    Penny Stock Current Share Price Law Week’s Gain
    Seadrill Ltd. (NYSE: SDRL) $0.58 98.74%
    Vivis Inc. (Nasdaq: VVUS) $0.83 59.97%
    MEI Pharma Inc. (Nasdaq: MEIP) $3.45 43.40%
    Transenterix Inc. (NYSE: TRXC) $3.15 35.72%
    Akers Biosciences Inc. (Nasdaq: AKER) $0.65 34.38%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $4.54 32.58%
    Phoenix New Media Ltd. (NYSE ADR: FENG) $5.65 32.22%
    Heat Biologics Inc. (Nasdaq: HTBX) $1.73 31.37%
    Bright Scholar Education Ltd. (NYSE ADR: BEDU) $18.51 29.03%
    21 Vianet Group Inc. (Nasdaq: VNET) $7.36 28.72%

    These gains are incredibly exciting. However, not all penny stocks are equally strong investments.

  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we’ll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month’s Gain
     Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85%
    Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40%
    Vivis Inc. (Nasdaq: VVUS) $0.77 150.41%
    Adomani Inc. (Nasdaq: ADOM) $1.49 137.68%
    NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88%
    Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06%
    Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12%
    ArQule Inc. (Nasdaq: ARQL) $4.88 90.74%
    LiqTech International Inc. (NYSE: LIQT) $0.66 85.60%
    Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month’s gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

Top 10 Clean Energy Stocks To Own For 2019: Lam Research Corporation(LRCX)

Advisors’ Opinion:

  • [By Keith Noonan]

    Lam Research Corp. (NASDAQ:LRCX) stock climbed 10.3 % in July, according to data provided by S&P Global Market Intelligence . The company’s share price moved higher in the middle of the month after earnings results and guidance from competitor ASML Holdings LV suggested a stronger semiconductor-equipment industry outlook. However, Lam’s biggest stock gains occurred following its own fiscal fourth-quarter earnings release in late July.

  • [By Billy Duberstein]

    Like the semiconductor and memory industries, the semiconductor equipment industry has consolidated, to a handful of key global players. Two of the largest are U.S. companies Lam Research (NASDAQ:LRCX) and Applied Materials (NASDAQ:AMAT).

  • [By Joseph Griffin]

    Here are some of the media stories that may have effected Accern Sentiment’s rankings:

    ACM Research Shares Could Fall When IPO Lockup Expires (seekingalpha.com) Applied Materials and Lam Research Fell on April 19 (finance.yahoo.com) The Zacks Analyst Blog Highlights: IBM, McDonald's, Gilead, Phillips 66 and Lam Research (finance.yahoo.com) FY2019 Earnings Estimate for Lam Research Issued By KeyCorp (LRCX) (americanbankingnews.com) Q4 2018 Earnings Forecast for Lam Research (LRCX) Issued By B. Riley (americanbankingnews.com)

    Shares of LRCX stock traded up $1.52 during trading hours on Friday, hitting $191.91. 4,980,703 shares of the company’s stock were exchanged, compared to its average volume of 3,910,779. The company has a debt-to-equity ratio of 0.26, a quick ratio of 2.09 and a current ratio of 2.64. The stock has a market capitalization of $33,204.83, a PE ratio of 19.23, a PEG ratio of 0.67 and a beta of 1.41. Lam Research has a 52 week low of $137.55 and a 52 week high of $234.88.

  • [By Shane Hupp]

    Greenleaf Trust bought a new stake in Lam Research Co. (NASDAQ:LRCX) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,346 shares of the semiconductor company’s stock, valued at approximately $233,000.

  • [By ]

    The third caller had Boeing (BA) , Helmerich & Payne (HP) , Fiat Chrysler (FCAU) , LAM Research (LRCX) and Steel Dynamics (STLD)  as her top five stocks.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Friday was Lam Research Corp. (NASDAQ: LRCX) which rose about 6% to $224.87. The stock’s 52-week range is $118.37 to $226.08. Volume was over 6 million compared to the daily average volume of 3.6 million.

Top 10 Clean Energy Stocks To Own For 2019: Martin Midstream Partners L.P.(MMLP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Master limited partnerships (MLPs) Buckeye Partners (NYSE:BPL) and Martin Midstream Partners (NASDAQ:MMLP) currently yield a jaw-dropping 13.7% and 17.4%, respectively. Both payouts are well above the 8% average yield of MLPs held in the Alerian MLP Index, which is a clear sign that the market doesn’t believe in the long-term viability of these payouts. Their unsustainability is even more apparent when we look at the embarrassingly weak financial profiles currently backing these payouts, which is why investors should steer clear of these high-yield stocks.

  • [By Matthew DiLallo]

    ONEOK (NYSE:OKE) has made several shrewd moves over the past few years, which have positioned it to grow its high-yielding dividend at a high rate. One of the latest is its recent deal to buy out Martin Midstream Partners’ (NASDAQ:MMLP) 20% interest in the West Texas LPG pipeline system. With full control of that pipeline, the company can more aggressively pursue expansion opportunities, which recently led it to secure a second project on the system that positions it for even more growth in the future.

  • [By Joseph Griffin]

    Martin Midstream Partners L.P. (NASDAQ:MMLP) – Equities research analysts at Capital One Financial lowered their FY2018 earnings per share estimates for shares of Martin Midstream Partners in a report released on Thursday, February 14th. Capital One Financial analyst K. May now forecasts that the pipeline company will earn $0.12 per share for the year, down from their previous estimate of $0.14. Capital One Financial also issued estimates for Martin Midstream Partners’ Q4 2018 earnings at $0.22 EPS and FY2020 earnings at $0.82 EPS.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Martin Midstream Partners (MMLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Own For 2019: Erie Indemnity Company(ERIE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Erie Indemnity (ERIE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Econ Financial Services Corp acquired a new stake in shares of Erie Indemnity (NASDAQ:ERIE) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 24,237 shares of the financial services provider’s stock, valued at approximately $3,231,000. Erie Indemnity accounts for 4.9% of Econ Financial Services Corp’s investment portfolio, making the stock its largest position.

  • [By Joseph Griffin]

    Wedgewood Investors Inc. PA trimmed its holdings in shares of Erie Indemnity Company Class A (NASDAQ:ERIE) by 2.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 51,933 shares of the financial services provider’s stock after selling 1,201 shares during the quarter. Erie Indemnity Company Class A accounts for approximately 10.4% of Wedgewood Investors Inc. PA’s portfolio, making the stock its biggest position. Wedgewood Investors Inc. PA’s holdings in Erie Indemnity Company Class A were worth $6,090,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Crawford & Company (NYSE:CRD.A) and Erie Indemnity (NASDAQ:ERIE) are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, profitability and valuation.

Top 10 Clean Energy Stocks To Own For 2019: Invesco Trust for Investment Grade Municipals(VGM)

Advisors’ Opinion:

  • [By Max Byerly]

    Media headlines about Invesco Van Kmpn Trst Fr Invst Grd Mncpl (NYSE:VGM) have been trending somewhat positive recently, Accern reports. The research group scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Invesco Van Kmpn Trst Fr Invst Grd Mncpl earned a news impact score of 0.19 on Accern’s scale. Accern also gave headlines about the investment management company an impact score of 46.4657191418091 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 10 Clean Energy Stocks To Own For 2019: Plains All American Pipeline L.P.(PAA)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    It’s also just one of several oil pipeline projects in the works throughout the Permian Basin. Plains All American Pipeline (NYSE:PAA) is currently investing $1.6 billion on Permian Basin expansions, which include two long-haul pipelines and several other complementary projects to help de-bottleneck the flow of crude. Those projects help position Plains to grow earnings and cash flow at a double-digit annual pace over the next two years, setting it up to increase its 4.9%-yielding payout at a healthy rate going forward.

  • [By Matthew DiLallo]

    Plains All American Pipeline, L.P. (NYSE:PAA) continued its turnaround in the second quarter as recently completed expansion projects helped drive earnings higher. While its financial results weren’t quite as impressive as they were in the first quarter due to the impact of seasonality and asset sales, it still was a noticeable step forward for a company that has had its share of challenges in recent years.

  • [By Matthew DiLallo]

    One oil midstream company that meets all these criteria is Plains All American Pipelines (NYSE:PAA). While the oil pipeline MLP did struggle during the recent oil market downturn, it’s working to address those issues, which positions it to deliver better returns for investors in the coming years. Among the problems it’s fixing is its balance sheet, with Plains’ aim to get its leverage ratio to less than 4.0 times by early next year. Meanwhile, the company has invested heavily in strengthening its portfolio of fee-bearing assets so that long-term contracts now support 90% of its earnings. Finally, Plains only expects to pay out about 60% of its cash flow to support its high-yield dividend in 2018, which is an ultra-conservative level for an oil pipeline stock.

Top 10 Clean Energy Stocks To Own For 2019: Sally Beauty Holdings, Inc.(SBH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Sally Beauty (SBH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Sally Beauty (SBH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Sally Beauty (NYSE:SBH)‘s stock had its “market perform” rating reaffirmed by equities researchers at Cowen in a research report issued on Wednesday. The analysts noted that the move was a valuation call.

  • [By Max Byerly]

    Itau Unibanco Holding S.A. acquired a new stake in shares of Sally Beauty Holdings, Inc. (NYSE:SBH) during the 2nd quarter, HoldingsChannel.com reports. The firm acquired 6,418 shares of the specialty retailer’s stock, valued at approximately $103,000.

Top 10 Clean Energy Stocks To Own For 2019: Kitov Pharamceuticals Holdings Ltd.(KTOV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

  • [By Lisa Levin]

    Kitov Pharma Ltd (NASDAQ: KTOV) shares dropped 16 percent to $2.56. Kitov Pharma priced its 3.26 million ADS offering at $2.50 per ADS.

    Shares of Ambow Education Holding Ltd. (NASDAQ: GLNG) were down 28 percent to $4.10.

  • [By Lisa Levin] Gainers
    TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading.
    Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion.
    DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading.
    Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading.
    Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading.
    Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading.
    Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading.
    Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results.
    Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Shane Hupp]

    Ardelyx (NASDAQ: ARDX) and KITOV PHARMA LT/S (NASDAQ:KTOV) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends.

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 65.5 percent to $179.50 in pre-market trading. Madrigal Pharma disclosed that MGL-3196 achieved liver biopsy endpoints in patients with NASH at 36 weeks in Phase 2 trial.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 34.8 percent to $6.70 in pre-market trading after falling 4.42 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares rose 31.5 percent to $2.19 in pre-market trading after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Curis, Inc. (NASDAQ: CRIS) shares rose 27.2 percent to $2.90 in pre-market trading after the company reported FDA Fast Track designation for CUDC-907 development in patients with relapse, refractory diffuse large B-cell lymphoma.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 16.7 percent to $2.51 in pre-market trading.
    Tilly's, Inc. (NYSE: TLYS) rose 14.7 percent to $14.00 in pre-market trading as the company reported better-than-expected earnings for its first quarter and issued a strong Q2 outlook.
    Express, Inc. (NYSE: EXPR) rose 14.3 percent to $10.49 in pre-market trading after the company reported better-than-expected results for its first quarter.
    NGL Energy Partners LP (NYSE: NGL) rose 12.8 percent to $12.10 in pre-market trading after reporting Q4 earnings beat.
    J.Jill, Inc. (NYSE: JILL) rose 11.3 percent to $6.90 in pre-market trading after the company posted upbeat quarterly earnings.
    TapImmune, Inc. (NASDAQ: TPIV) shares rose 10 percent to $5.60 in pre-market trading after climbing 24.15 percent on Wednesday.
    Frontline Ltd. (NYSE: FRO) rose 9.8 percent to $5.74 in pre-market trading after Q1 results beat estimates.
    Tech Data Corporation (NASDAQ: TECD) rose 8.8 percent to $89.65 in pre-market trading following better-than-expected Q1 earnings.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 7.1 percent to $3.65 in pre-market tra
  • [By Lisa Levin]

    Kitov Pharma Ltd (NASDAQ: KTOV) shares dropped 14 percent to $2.6000. Kitov Pharma priced its 3.26 million ADS offering at $2.50 per ADS.

    Shares of Ambow Education Holding Ltd. (NASDAQ: AMBO) were down 25 percent to $4.26.

Best Value Stocks For 2019

Pacific Heights Asset Management LLC trimmed its holdings in shares of Morgan Stanley (NYSE:MS) by 18.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 215,000 shares of the financial services provider’s stock after selling 50,000 shares during the quarter. Pacific Heights Asset Management LLC’s holdings in Morgan Stanley were worth $11,601,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Whittier Trust Co. of Nevada Inc. lifted its position in shares of Morgan Stanley by 406.5% during the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 1,869 shares of the financial services provider’s stock valued at $101,000 after acquiring an additional 1,500 shares during the period. Exane Derivatives lifted its position in shares of Morgan Stanley by 303.9% during the 4th quarter. Exane Derivatives now owns 1,979 shares of the financial services provider’s stock valued at $104,000 after acquiring an additional 1,489 shares during the period. First Dallas Securities Inc. acquired a new position in shares of Morgan Stanley during the 4th quarter valued at $121,000. Guidant Wealth Advisors acquired a new position in shares of Morgan Stanley during the 4th quarter valued at $132,000. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its position in shares of Morgan Stanley by 119.4% during the 4th quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,800 shares of the financial services provider’s stock valued at $147,000 after acquiring an additional 1,524 shares during the period. 86.98% of the stock is currently owned by hedge funds and other institutional investors.

Best Value Stocks For 2019: Kura Oncology, Inc.(KURA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Kura Oncology (NASDAQ:KURA) was the target of unusually large options trading on Thursday. Stock investors bought 699 put options on the company. This represents an increase of 694% compared to the typical daily volume of 88 put options.

Best Value Stocks For 2019: Avago Technologies Limited(AVGO)

Advisors’ Opinion:

  • [By ]

    The path has been beset with challenges, from a hostile takeover attempt by Hock Tan’s Broadcom Corp. (AVGO) to an epic IP battle with Apple Inc. (AAPL) and a landmark acquisition of NXP Semiconductors NV (NXPI) that faced an activist campaign by Elliott Management Corp. and a protracted review by regulators in China.

  • [By Garrett Baldwin]

    Shares of General Electric Co. (NYSE: GE) are in focus after the company reported earnings before the bell. GE stock popped 5.6% after the firm topped earnings per share (EPS) estimates by $0.05 and backed its 2018 outlook. The firm reported EPS of $0.16 on top of $28.66 billion in revenue. GE stock had been off nearly 18% from its last earnings report on January 24 due to ongoing financial and legal problems.
    Crude oil prices dipped Friday after U.S. President Donald Trump took aim at OPEC. Trump accused the cartel of keeping oil prices “artificially high” despite “record amounts of oil all over the place.” Brent crude and WTI crude oil both hit three-year highs this week after Saudi Arabia suggested that it was working to press oil prices back above $100 per barrel.
    Three Stocks to Watch Today: PM, MO, WFC
    Shares of Philip Morris International Inc.(NYSE: PM) fell this morning after the firm experienced its worst trading day since its spin-off from Altria Group Inc. (NYSE: MO). Shares of PM fell as much as 16% after the firm fell short of revenue expectations after the bell. MO stock fell roughly 6% on the day.
    Shares of Wells Fargo & Co. (NYSE: WFC) are under pressure after The New York Times reported that the firm may be facing a $1 billion fine. The fines would cover a variety of “alleged” misdeeds that include the firm’s push on customers to purchase auto insurance they didn’t need and charging mortgage customers fees for services that they were not using. The Consumer Financial Protection Bureau and the Office of the Comptroller of the Currency will most likely announce the fine today. Money MorningCapital Wave StrategistShah Gilani weighed in on the topic this week, and he offers a scorching indictment.
    Qualcomm Inc. (Nasdaq: QCOM) is on the move today after the semiconductor giant announced plans to lay off 1,500 employees. The cuts are expected to hit employees in California and cities around the globe. The cuts are part of the fi

  • [By Timothy Green]

    After trying and failing to acquire mobile-chip giant Qualcomm, Broadcom (NASDAQ:AVGO) has turned its attention to other targets. The company announced on July 11 that it had agreed to pay $18.9 billion in cash for CA Technologies (NASDAQ:CA), a software company that derives about half its revenue and most of its profits from software and solutions for mainframe systems. Broadcom is making a very big bet on big iron.

  • [By Ashraf Eassa]

    Earlier this year, in the midst of the drama surroundingBroadcom’s (NASDAQ:AVGO) attempted takeover of Qualcomm,Jacobs relinquished his role as chairman but stayed on as a director. Then, shortly after rumors began to surface that he was trying to take Qualcomm private, Jacobs was kicked off the board of directors.

  • [By Ashraf Eassa]

    In November 2017, chip giant Broadcom (NASDAQ:AVGO) offered to buy fellow chipmakerQualcomm (NASDAQ:QCOM) for $70 per share, a 28% premium to Qualcomm’s closing price before speculation about the bid leaked. Qualcomm shares had been significantly depressed prior to Broadcom’s offer amid an ugly legal battle with Apple (NASDAQ:AAPL) that threatened to destroy Qualcomm’s wireless technology licensing operation — its biggest profit center.

Best Value Stocks For 2019: Vascular Biogenics Ltd.(VBLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    ReTo Eco-Solutions, Inc. (NASDAQ: RETO) fell 9.3 percent to $4.50 in pre-market trading.
    ProPhase Labs, Inc. (NASDAQ: PRPH) shares fell 8.5 percent to $4.50 in pre-market trading after dropping 3.53 percent on Thursday.
    Nordstrom, Inc. (NYSE: JWN) fell 7.5 percent to $47.10 in pre-market trading. Nordstrom reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent.
    Baidu, Inc. (NASDAQ: BIDU) shares fell 6 percent to $263.00 in pre-market trading. Baidu disclosed that its COO Qi Lu will step down in July 2018.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares fell 5.6 percent to $8.98 in pre-market trading after climbing 11.88 percent on Thursday.
    Applied Materials, Inc. (NASDAQ: AMAT) fell 5 percent to $51.30 in pre-market trading. Applied Materials reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter.
    Blink Charging Co. (NASDAQ: BLNK) fell 5 percent to $7.61 in pre-market trading after rising 11.40 percent on Thursday.
    Illumina, Inc. (NASDAQ: ILMN) shares fell 4.7 percent to $255.77 in pre-market trading.
    Vascular Biogenics Ltd (NASDAQ: VBLT) fell 4.6 percent to $2.10 in pre-market trading after reporting a first-quarter earnings miss.
    Campbell Soup Company (NYSE: CPB) fell 3.3 percent to $37.60 in pre-market trading. Campbell Soup reported upbeat Q3 earnings, but sales missed estimates. The company also lowered its FY18 outlook.
    ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 2.7 percent to $17.65 in pre-market trading after reporting a 7.2 million common stock offering

  • [By Lisa Levin] Companies Reporting Before The Bell
    Walmart Inc. (NYSE: WMT) is estimated to report quarterly earnings at $1.13 per share on revenue of $120.51 billion.
    J. C. Penney Company, Inc. (NYSE: JCP) is expected to report quarterly loss at $0.2 per share on revenue of $2.63 billion.
    Dillard's, Inc. (NYSE: DDS) is projected to report quarterly earnings at $2.77 per share on revenue of $1.46 billion.
    The Children's Place, Inc. (NASDAQ: PLCE) is estimated to report quarterly earnings at $2.21 per share on revenue of $444.14 million.
    Manchester United plc (NYSE: MANU) is expected to report quarterly loss at $1.35 per share on revenue of $193.67 million.
    Teekay Corporation (NYSE: TK) is estimated to report quarterly loss at $0.08 per share on revenue of $296.76 million.
    KEMET Corporation (NYSE: KEM) is projected to report quarterly earnings at $0.41 per share on revenue of $306.72 million.
    Vascular Biogenics Ltd. (NASDAQ: VBLT) is estimated to report a quarterly loss at $0.21 per share.
    Teekay Offshore Partners L.P. (NYSE: TOO) is expected to report quarterly earnings at $0.04 per share on revenue of $272.04 million.
    Albireo Pharma, Inc. (NASDAQ: ALBO) is expected to report quarterly earnings at $1.77 per share on revenue of $31.32 million.

     

Best Value Stocks For 2019: Xinyuan Real Estate Co Ltd(XIN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Mixin (CURRENCY:XIN) traded up 6.2% against the U.S. dollar during the 1-day period ending at 20:00 PM E.T. on July 17th. One Mixin token can currently be purchased for approximately $550.98 or 0.07481400 BTC on popular cryptocurrency exchanges. Mixin has a total market cap of $241.93 million and approximately $90,201.00 worth of Mixin was traded on exchanges in the last day. Over the last week, Mixin has traded up 19.1% against the U.S. dollar.

  • [By Shane Hupp]

    Xinyuan Real Estate Co., Ltd. (NYSE:XIN) declared a quarterly dividend on Wednesday, May 30th, RTT News reports. Stockholders of record on Monday, June 11th will be given a dividend of 0.05 per share by the financial services provider on Friday, June 22nd. This represents a $0.20 annualized dividend and a dividend yield of 3.74%.

  • [By Ethan Ryder]

    Mixin (XIN) is a proof-of-stake (PoS) token that uses the SHA256 hashing algorithm. It launched on October 2nd, 2017. Mixin’s total supply is 1,000,000 tokens and its circulating supply is 438,115 tokens. Mixin’s official message board is mixin.one/logs. Mixin’s official Twitter account is @XIN_Foundation and its Facebook page is accessible here. The official website for Mixin is mixin.one.

Best Value Stocks For 2019: Chatham Lodging Trust (REIT)(CLDT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Chatham Lodging Trust (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Chatham Lodging Trust (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Chatham Lodging Trust (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Chatham Lodging (NYSE:CLDT) announced a monthly dividend on Thursday, May 10th, Zacks reports. Shareholders of record on Thursday, May 31st will be paid a dividend of 0.11 per share by the real estate investment trust on Friday, June 29th. This represents a $1.32 annualized dividend and a yield of 6.38%. The ex-dividend date of this dividend is Wednesday, May 30th.

Top Stocks To Watch For 2019

April 26 was a great day to be aChipotle Mexican Grill, Inc.(NYSE:CMG) shareholder. Following the release of the company’s first-quarter earnings after market close the day before, Chipotle’s stock price surged an incredible 24%, capping a remarkable 69% run since Brian Niccol was named CEO on February 13.

Did the company deliver? In short, yes and no. Sales were up 7.4%, same-store sales (also called comps) increased 2.2%, and earnings per share jumped 33%. But even as profits and sales improved, Chipotle continues to struggle to bring back customers: Comps growth was entirely due to a 4.9% average price increase, and fewer customers ate at Chipotle than in the year-ago quarter.

But Niccol aims to change that, and it looks like Mr. Market is buying into Niccol’s vision and expectations that he will deliver the kind of growth results he did as CEO ofYUM Brands’ Taco Bell unit. Let’s take a closer look at Chipotle’s quarterly results, as well as what Niccol had to say about his plans to continue turning the company around.

Top Stocks To Watch For 2019: Almost Family Inc(AFAM)

Advisors’ Opinion:

  • [By Max Byerly]

    Schwab Charles Investment Management Inc. boosted its position in shares of Almost Family Inc (NASDAQ:AFAM) by 12.6% during the first quarter, HoldingsChannel reports. The firm owned 62,175 shares of the company’s stock after buying an additional 6,953 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in Almost Family were worth $3,482,000 at the end of the most recent reporting period.

Top Stocks To Watch For 2019: Enduro Royalty Trust(NDRO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Enduro Royalty Trust (NDRO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

Top Stocks To Watch For 2019: Entergy Louisiana, Inc.(ELA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Elastos (CURRENCY:ELA) traded down 2.3% against the dollar during the 1-day period ending at 20:00 PM E.T. on June 19th. Elastos has a market capitalization of $150.76 million and approximately $6.03 million worth of Elastos was traded on exchanges in the last day. In the last seven days, Elastos has traded 6.9% lower against the dollar. One Elastos coin can currently be bought for $28.91 or 0.00428971 BTC on major exchanges including Huobi and BCEX.

Top Stocks To Watch For 2019: Vanguard Value ETF (VTV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Dynamic Advisor Solutions LLC bought a new stake in Vanguard Value ETF (NYSEARCA:VTV) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,421 shares of the company’s stock, valued at approximately $353,000.

Top Stocks To Watch For 2019: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Chris Lange]

    Juniper Pharmaceuticals Inc. (NASDAQ: JNP) shares rallied early on Tuesday after the company announced that it would be acquired by Catalent. The transaction is expected to close in the third quarter of 2018.

Top Stocks To Watch For 2019: Kura Oncology, Inc.(KURA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Kura Oncology (NASDAQ:KURA) was the target of unusually large options trading on Thursday. Stock investors bought 699 put options on the company. This represents an increase of 694% compared to the typical daily volume of 88 put options.

Hot Canadian Stocks To Watch For 2019

The U.S. stock markets hit the jackpot in 2017, with all the major indexes up significantly — the S&P 500 gained 19% over the past year, the Dow Jones Industrial Average was up 25% and the tech-heavy Nasdaq was up an impressive 28% — making year-end assessments by investors a very happy occasion.

Amazingly, the U.S, markets ranked 39th out of 47 countries in 2017, making this past year a relative stinker compared to the rest of the world’s stocks.

Why the “down” year?

It’s possible that investors have figured out that U.S. stocks are overvalued relative to stocks in other countries. So, while U.S. markets underperformed on a comparable basis, it can always be worse, as Canada demonstrates.

In 2017, Canadian stocks gained just 6% on the year with energy companies providing a significant headwind to better performance. Here in the U.S., the major indexes are much less dependent on energy stocks, hence the higher returns.

Hot Canadian Stocks To Watch For 2019: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ELEKTA AB/ADR (OTCMKTS: EKTAY) and Genomic Health (NASDAQ:GHDX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings.

  • [By Stephan Byrd]

    Genomic Health, Inc. (NASDAQ:GHDX) insider Kimberly J. Popovits sold 10,000 shares of Genomic Health stock in a transaction on Thursday, June 14th. The shares were sold at an average price of $48.89, for a total value of $488,900.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

  • [By Shane Hupp]

    Genomic Health (NASDAQ: GHDX) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

  • [By Logan Wallace]

    Carillon Tower Advisers Inc. bought a new position in shares of Genomic Health (NASDAQ:GHDX) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 75,375 shares of the medical research company’s stock, valued at approximately $2,358,000.

Hot Canadian Stocks To Watch For 2019: Kura Oncology, Inc.(KURA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Kura Oncology (NASDAQ:KURA) was the target of unusually large options trading on Thursday. Stock investors bought 699 put options on the company. This represents an increase of 694% compared to the typical daily volume of 88 put options.

Hot Canadian Stocks To Watch For 2019: Landec Corporation(LNDC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Landec (LNDC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com